Allegro

The AI engine Fit Assessment

Beta

Allegro is a company focused on developing advanced biomedical technologies, particularly in the fields of rheumatology and orthopedics. They utilize nanotechnology to create innovative treatments for chronic degenerative diseases, including a disease-modifying therapy for osteoarthritis.

Blurb

Game-changing therapeutic nanoparticles for neuroscience, chronic degenerative diseases and orthopaedics.

HQ Location

Belgium

Founded

2021

Employees

1 - 10

Total funding raised

$7.73M

Last Funding Event

Seed, $6.04M, April 25, 2023

Smart insights

Not available

Developer of an artificial intelligence nanotechnology platform designed for orthopedics, rheumatology, immunology, and chronic degenerative diseases. The company offers hydrogel injection to restore the mechanics of the joint, which is the fundamental cause of osteoarthritis, enabling researchers to invent a nanotechnology scaffold for orthopedics, rheumatology, and regenerative medicine.